AZN icon

AstraZeneca

1,369 hedge funds and large institutions have $45.1B invested in AstraZeneca in 2025 Q4 according to their latest regulatory filings, with 242 funds opening new positions, 490 increasing their positions, 411 reducing their positions, and 119 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1,369
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$591M
Puts
$420M
Net Calls
Net Calls Change

Top Buyers

1 +$420M
2 +$412M
3 +$327M
4
Citigroup
Citigroup
New York
+$204M
5
Barclays
Barclays
United Kingdom
+$180M

Top Sellers

1 -$924M
2 -$831M
3 -$550M
4
Primecap Management
Primecap Management
California
-$258M
5
Citadel Advisors
Citadel Advisors
Florida
-$241M
Name Holding Trade Value Shares
Change
Change in
Stake
CAM
1426
CenterStar Asset Management
Illinois
SM
1427
Stonegate Management
Illinois
CW
1428
CreativeOne Wealth
Kansas
SP
1429
Saranac Partners
LCGC
1430
Legacy Capital Group California
California
PVI
1431
Pine Valley Investments
New Jersey
BBW
1432
Blue Barn Wealth
Utah
GAG
1433
GM Advisory Group
New York
CPRC
1434
Consolidated Portfolio Review Corp
New York
NP
1435
NorthRock Partners
Minnesota
JG
1436
Jain Global
New York
APA
1437
Astoria Portfolio Advisors
New York
AP
1438
Advisors Preferred
Maryland
PFA
1439
Pure Financial Advisors
California
BAM
1440
Blueshift Asset Management
New Jersey
SA
1441
Sonoma Allocations
California
MFG
1442
MidWestOne Financial Group
Iowa
SB
1443
SIG Brokerage
New York
BFA
1444
Beaumont Financial Advisors
Massachusetts
NEPPG
1445
New England Professional Planning Group
Rhode Island
BCM
1446
Bayesian Capital Management
New York
AO
1447
Advisor OS
Illinois
AGA
1448
Accuvest Global Advisors
Utah
FMWA
1449
Forvis Mazars Wealth Advisors
Missouri
MM
1450
MQS Management
New York